Clinical Trials on Lysinuric Protein Intolerance in Ireland
Total 159 results
-
Cambridge GlycoscienceCompletedGastrointestinal ToleranceIreland
-
Atlantia Food Clinical TrialsCaelus Pharmaceuticals BVCompletedGlucose Metabolism Disorders | Metabolic Syndrome | Insulin Resistance | Impaired Glucose Tolerance | Insulin Sensitivity | Pre DiabetesIreland, United States, United Kingdom
-
University College DublinKerry GroupCompletedMuscle Weakness | Old Age; Debility | Protein Deposition | Protein DeregulationIreland
-
Atlantia Food Clinical TrialsTerminated
-
Forest LaboratoriesCompleted
-
University College DublinActive, not recruitingGlucose Intolerance | Healthy Subjects | Postprandial Hyperglycemia | Glycemic Control | Diabetes Mellitus RiskIreland
-
Marjukka KolehmainenLund University; Uppsala University; Aarhus University Hospital; University of... and other collaboratorsCompletedCardiovascular Diseases | Insulin Resistance | Type 2 Diabetes | Impaired Glucose Tolerance | Abdominal ObesitySweden, Denmark, Finland, Iceland, Norway
-
Arete TherapeuticsCompletedHypertension | Impaired Glucose ToleranceUnited States
-
University College DublinRecruitingDiabetes Mellitus, Type 2 | Glucose Intolerance | Healthy Diet | Postprandial HyperglycemiaIreland
-
University of LimerickMarigot Ltd.; Enterprise IrelandCompletedBioavailability of Amino Acids Following Oral Ingestion of Plant-Based Proteins in Young, Healthy MenIreland
-
Queen's University, BelfastNorthern Ireland Chest Heart and Stroke; HSC Research & Development Division... and other collaboratorsCompletedInsulin Resistance | Pre-diabetes | Sub-optimal Vitamin D StatusUnited Kingdom
-
Belfast Health and Social Care TrustQueen's University, BelfastTerminatedGestational DiabetesUnited Kingdom
-
University of AkureyriWestern Norway University of Applied SciencesCompletedCardiovascular Risk Factor | Primary Health Care | Pre-diabetes | T2DM (Type 2 Diabetes Mellitus)Iceland
-
National University of Ireland, Galway, IrelandJanssen Pharmaceuticals; Cancer Trials IrelandUnknownMultiple MyelomaIreland
-
St. James's Hospital, IrelandBaxter BioScienceUnknownSevere Haemophilia AIreland
-
University College CorkCancer Research@UCCRecruiting
-
The University of Hong KongTung Wah Eastern HospitalCompleted
-
Cancer Trials IrelandBristol-Myers Squibb; Janssen PharmaceuticalsActive, not recruiting
-
Rhode Island HospitalBrown UniversityNot yet recruitingLong COVID | Distress ToleranceUnited States
-
Cancer Trials IrelandCompleted
-
Cancer Trials IrelandSanofi; Dana-Farber Cancer InstituteRecruitingMultiple MyelomaDenmark, Ireland
-
University of IcelandMemorial Sloan Kettering Cancer Center; Landspitali University Hospital; deCODE... and other collaboratorsActive, not recruitingMonoclonal Gammopathy of Undetermined SignificanceIceland
-
Landspitali University HospitalMemorial Sloan Kettering Cancer Center; Celgene; Amgen; University of IcelandEnrolling by invitationMultiple Myeloma | Smoldering Multiple MyelomaIceland
-
ValbiotisInstitut Pasteur de Lille; Biofortis Mérieux NutriSciencesCompletedObesity | Disease | Insulin Resistance | Type 2 Diabetes | Hypertriglyceridemia | PrediabetesFrance, Ireland, Serbia, Slovenia
-
University of Prince Edward IslandCompletedPhysical Activity | Glucose Tolerance | Insulin Sensitivity | Sedentary BehaviourCanada
-
Cancer Trials IrelandCompleted
-
Abbott NutritionCompleted
-
Janssen Research & Development, LLCNo longer availableRelapsed or Refractory Multiple MyelomaBelgium, Iceland, Portugal, Slovenia
-
Salmon, Margaret, M.D.Bill and Melinda Gates Foundation; Akeso Associates; Eastern Congo Initiative; HEAL...UnknownAnemia | Exercise Tolerance | Hookworm Stool BurdenCongo
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
GlycoMimetics IncorporatedCompletedMultiple MyelomaIreland, Denmark, United Kingdom, Germany
-
Baxalta now part of ShireCompleted
-
Brown UniversityAstraZenecaRecruitingEsophageal Cancer | Esophageal Adenocarcinoma | HER-2 Protein Overexpression | Gastroesophageal-junction CancerUnited States
-
John L. ReaganThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode IslandActive, not recruiting
-
West of Scotland Lymphoma GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
University College, LondonTerminatedHemophilia BIreland, United Kingdom, Italy, United States
-
Swedish Orphan BiovitrumBioverativ Therapeutics Inc.CompletedHemophilia AIreland, United Kingdom, Germany, United States, Canada, Slovenia, Sweden
-
Swedish Orphan BiovitrumCerner EnvizaCompletedHemophilia A With InhibitorFrance, Ireland, Italy, Norway, Germany, Kuwait, Saudi Arabia, Switzerland
-
H. Lundbeck A/SCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States
-
Brown UniversityThe Miriam Hospital; Rhode Island Hospital; Spectrum Pharmaceuticals, IncCompletedLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, B-Cell, Marginal Zone | Waldenstrom Macroglobulinemia | Lymphoma, Small-CellUnited States
-
NovartisCompletedMultiple MyelomaCanada, United States, Australia, Taiwan, Ireland
-
Swedish Orphan BiovitrumCerner EnvizaActive, not recruitingHemophilia BCzechia, Greece, Ireland, Italy, Norway, Saudi Arabia, Spain, Sweden, United Kingdom
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.CompletedMultiple MyelomaNorway, Sweden, Denmark, Finland, Iceland
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedHemophilia BUnited States, United Kingdom, South Africa, Netherlands, Ireland, Australia
-
PfizerBristol-Myers SquibbRecruiting
-
AstraZenecaTerminatedElevated High-sensitivity C-Reactive Protein (hsCRP)United States, Brazil, Bulgaria, Poland, Russian Federation, South Africa, United Kingdom, Germany, Estonia, Romania, Denmark, Netherlands, Norway, Canada, Mexico, Belgium, Israel, Puerto Rico, Colombia, Argentina, Venezuela, Panama, Urugu... and more
-
Chelsea TherapeuticsChiltern International Inc.CompletedA Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa (NOH301)Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension (NOH) | Non-diabetic NeuropathyUnited States, Canada
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States